20-HETE and furosemide-induced natriuresis in salt-sensitive essential hypertension

Hypertension

Volumn 41, Issue 3 II, 2003, Pages 703-708

  Laffer, Cheryl L ^a,c   Laniado Schwartzman, Michal ^b   Wang, Mong Heng ^b   Nasjletti, Alberto ^b   Elijovich, Fernando ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c Hypertension Center   (United States)

Author keywords

Arachidonic acid; Furosemide; Human; Hypertension, sodium dependent; Natriuresis; Risk factors; Sodium

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ALDOSTERONE; FUROSEMIDE; RENIN; SODIUM; SODIUM CHLORIDE;

ADULT; ALDOSTERONE BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIURESIS; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; NATRIURESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; TIME; URINE LEVEL;

ADULT; ALDOSTERONE; BLOOD PRESSURE; FEMALE; FUROSEMIDE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; HYPERTENSION; MALE; NATRIURESIS; RENIN; SODIUM; SODIUM CHLORIDE;

EID: 0037341856     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000051888.91497.47     Document Type: Conference Paper

References (29)

1. Yang H, Wang Z, Miyamoto Y, Reinach PS. Cell signaling pathways mediating epidermal growth factor stimulation of Na:K:2Cl cotransport activity in rabbit corneal epithelial cells. J Membrane Biol. 2001;183:93-101.
2. 2+ increase and apoptosis induced by pinacidil in HepG2 human hepatoblastoma cells. Biochem Biophys Res Comm. 2001;281:511-519.
3. Whisenant N, Zhang BX, Khademazad M, Loessberg P, Muallem S. Regulation of Na-K-2Cl cotransport in osteoblasts Am J Physiol. 1991;261:C433-C440.
4. +-2Cl-cotransporter, BSC-1. Am J Physiol. 1996;271:F619-F628.
5. Theilig F, Campean V, Paliege A, Breyer M, Briggs JP, Schnermann J, Bachmann S. Epithelial COX-2 expression is not regulated by nitric oxide in rodent renal cortex. Hypertension. 2002;39:848-853.
6. Mann B, Hartner A, Jensen BL, Kammerl M, Kramer BK, Kurtz A. Furosemide stimulates macula densa cyclooxygenase-2 expression in rats. Kidney Int. 2001;59:62-68.
7. Kammerl MC, Nusing RM, Richthammer W, Kramer BK, Kurtz A. Inhibition of COX-2 counteracts the effects of diuretics in rats. Kidney Int. 2001;60:1684-1691.
8. Stichtenoth DO, Wagner B, Frolich JC. Effect of selective inhibition of the inducible cyclooxygenase on renin release in healthy volunteers. J Invest Med. 1998;46:290-296.
9. 2 restores furosemide response in indomethacin-treated rats. Am J Physiol. 1986;250:F980-F985.
10. Bergamo RR, Cominelli F, Kopple JD, Zipser RD. Comparative acute effects of aspirin, diflunisal, ibuprofen and indomethacin on renal function in healthy man. Am J Nephrol. 1989;9:460-463.
11. Steinhauslin F, Munafo A, Buclin T, Macciocchi A, Biollaz J. Renal effects of nimesulide in furosemide-treated subjects. Drugs. 1993;46(Suppl 1):257-262.
12. +-ATPase. J Clin Invest. 1997;99:1224-1230.
13. Escalante B, Erlij D, Falck JR, McGiff JC. Cytochrome P-450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb. Am J Physiol. 1994;266:C1775-C1782.
14. + channel, ROMK1. Am J Physiol. 1996;271: F588-F594.
15. Roman RJ, Alonso-Galicia M, Wilson TW. Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats. Am J Hypertens. 1997;10:S63-S67.
16. Laffer CL, Laniado-Schwartzman M, Wang MH, Nasjletti A, Elijovich F. Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic acid in human salt-sensitive versus salt-resistant hypertension. Circulation. 2003;107:574-578.
17. Elijovich F, Laffer CL, Amador E, Gavras H, Bresnahan MR, Schiffrin EL. Regulation of plasma endothelin by salt in salt-sensitive hypertension. Circulation. 2001;103:263-268.
18. Sealey JE, Gerten-Banes J, Laragh JH. The renin system: variations in man measured by radioimmunoassay or bioassay. Kidney Intl. 1972;1:240-253.
19. Antunes JR, Dale SL, Melby JC. Simplified radioimmunoassay for aldosterone using antisera to aldosterone-gamma-lactone. Steroids. 1976;28:621-630.
20. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension. 2001;37:429-432.
21. Weinberger MH, Stegner JE, Fineberg NS. A comparison of two tests for the assessment of blood pressure responses to sodium. Am J Hypertens. 1993;6:179-184.
22. Collins RD, Weinberger MH, Dowdy AJ, Nokes GW, Gonzales CM, Leutscher JA. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension: relation to plasma renin. J Clin Invest. 1970;49:1415-1426.
23. Lim PO, Jung RT, MacDonald TM. Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity. J Human Hypertens. 2002;16:153-158.
24. Zou AP, Drummond HA, Roman RJ. Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr rats. Hypertension. 1996;27:631-635.
25. Scherer B, Witzgall H, Weber PC. Prostaglandin excretion after furosemide in normal and low-renin essential hypertension. Klin Woch. 1984;62:777-782.
26. 2 is not deficient in essential hypertension. Agents Actions. 1987;22:205-213.
27. - secretion in rabbit descending colon is mediated by prostaglandins. Biochim Biophys Acta. 1992;1107:139-142.
28. 2. Am J Physiol. 2001;280:F607-F618.
29. Ma YH, Schwartzman ML, Roman RJ. Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am J Physiol. 1994;267: R579-R589.